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Abstract
The high level of reported multidrug resistant pathogens with 
the failure of most conventional antibiotic to kill many of them arise 
the global concern in the last decade to find alternatives urgently. 
Many researches have been conducted on scorpion venom biological 
characteristics, and its different antimicrobial peptides had been 
reported in literature since the last decade. Here short overview of all 
scorpion AMPs with antibacterial activity, their structural determinants, 
classification types and their mode of action, in addition to their 
resistance mechanism and finally their therapeutics potential.
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Introduction 
Scorpions are one of the most ancient animals 
living on planet earth, having survived over 400 
million years, a time span that would impose several 
environmental pressures on the scorpions to evolve 
anatomically, conversely scorpions have conserved 
their morphology almost unaltered[1]which is 
mainly attributed to their development of a set of 
an efficient venom weapon to support their needs 
for prey and defense they are widely distributed all 
over the world and are represented by over 1500 
species[2].
Scorpions venomous glands contains a wide range 
of biological active molecules like enzymes, lipids, 
nucleotides, biogenic amines and other unknown 
molecules[3,4], also contains a large number of 
diverse peptides with different biological activities 
that are believed to be an integral component of 
an innate immune system that serves to protect the 
scorpion and its gland againsta variety of pathogen 
[5,6]. One of the most comprehensive methods to 
classify scorpion toxins is based upon their structural 
and biological features and by applying this method 
they can be classified into two major groups the 
disulfide bridged peptides (DBPs) reported to block 
the ion channels, including four types of toxins: 
K-, Cl-, Ca+2 and Na+ channels blockers[7,8] and 
thenon-disulfide bridged peptides  (NDBPs) is a less 
abundant group of peptides without disulfide bridges 
gain interest recently, they represent a wide range 
of biological activitieslikebradykinin potentiating, 
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anticancer, hemolytic, anti-inflammatory, immune-
modulatory and antimicrobial activities[9,10,11].
Many scorpion anti-microbial peptides had been 
functionally characterized in the last decade. Here 
quick overview of all scorpion AMPs with antibacterial 
activity,Structural Determinants, classification, mode 
of action, resistance and therapeutics potential.
Antimicrobial peptides (AMPs)
Antimicrobial peptides are one of the innate 
immune system components in a wide range of 
eukaryotic organisms like human, plant and insects; 
they play a vital role in early immune defense 
mechanisms against pathogens [12]. Defensins a 
peptides found inside human neutrophils consist of 
18-45 amino acid residues long, play a role in killing 
phagocytosed bacteria by membrane destruction 
and pore formation were the first antimicrobial 
peptides discovered on 1966 [13]. Since that time 
till now many AMPs with antibacterial activity have 
been isolated and functionally characterized from 
different scorpions species venoms (Table 1) [14].
These groups of peptides have been named 
host defense peptides after the discovery of 
additional immunological activities of it or in 
other way called HDPs to assess its multiple 
functions in innate immune system, also when 
these peptides have reported to have a direct 
antimicrobial activity they refer to it as cationic 
antimicrobial peptides [15].
Antimicrobial peptidesare short in length consist 
of amino acids ranging from 10 to 50 residues[16], 
with a net positive charge ranging from +2 to +9 
and the proportion of hydrophobic residues are 
equal or more than 30% of total amino acids 
residues[17], the positive amino acid residues are 
separated by patches of hydrophobic amino acids 
by this arrangement AMPs prevented to fold into 
amphipathic or amphiphilic structure usually at the 
contact with membranes or membranes mimics [15].
Because of AMPs sequences are highly diverse 
and there are many sequence similarities so classify 
AMPs according to sequence a rise many difficulties 
specially when trying to put peptide in different and 
specific classes. One of the most used techniques for 
classification is based on structural motifs homology 
[19]. Based on structural motifs homology, AMPs 
are classified into four main groups : more common 
groups α-helical peptides and β-sheet peptides, 
less common groups extended peptides and loops 
peptides among these α-helical peptides are the 
most studied group till now [20].
Scorpion AMPs with antibacterial activity against 
gram positive and gram negative bacterial strains 
had been documented by measuring the minimal 
inhibitory concentrations. Also some of these 
peptides have potent antibacterial activity while 
others have mild activity can be easy concluded 
from higher MIC values (Table 1) [14].
Structural determinants of 
antimicrobial activity
There are five interdependent types of structural 
components that determine the AMPs activity in 
which change in one factor affects the others [18]
Conformation: There are different ways to 
classify AMPs based on different criteria like 
peptide source, peptides precursors and peptides 
enrichment in one or more amino acids and based 
on other parameters [19]. AMPs vary in primary 
sequences and in origins but share some common 
structural motifs in their three dimensional topology 
they classified accordingly to two large groups α 
helical peptides and β sheets peptides, the other 
are less common groups contains loop peptides and 
extended peptides. The three dimensional structure 
is one of the factors that determine the activity 
and toxicity of AMPs by playing a role in the pore 
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Table 1.  List of all antimicrobial peptides with corresponding scorpion species and length as number of 
amino acidswithMIC values for both Gram negative and Gram positive strains 
Scorpion AMPs Length
MIC( µM)
Gram positive
MIC (µM)
Gram negative
Reference 
Hadrurusaztecus Hadrurin 41 10–50 10–50 [57]
Pandinus imperator Pandinin 1 44 1.3–5.2 20.8–20.8 [58]
Pandinus imperator Pandinin 2 24 2.4–4.8 19.1–38.2 [58]
Opistophtalmuscarinatus Opistoporin 1 44 12.5–50 1.6–50 [59]
Mesobuthusmartensii BmKb1 18 16–81.5 18.1–90.8 [60]
Mesobuthusmartensii BmKn2 13 0.6–8 1.5–21.3 [60]
Opisthacanthusmadagascariensis IsCT 13 0.7–16.6 3.3–150 [61]
Opisthacanthusmadagascariensis IsCT2 13 0.7–17.1 3.4–150 [61]
Parabuthusschlechteri Parabutoporin 45 6.3–50 1.6–50 [62]
Lychasmucronatus Mucroporin 17 25–50 >100 [63]
Mesobuthuseupeus Meucin-13 13 0.25–2.9 6.2–50 [64]
Mesobuthuseupeus Meucin-18 18 0.25–0.6 1.5–10.9 [64]
Isometrus maculates Imcroporin 17 20–50 >100 [72]
Scorpiopstibetanus StCT1 14 12.5–100 >100 [73]
Isometrusmaculatus Im-1 56 0.8–25 0.4–0.8 [65]
Vaejovismexicanus Vejovine 47 - 4.4 [76]
Chaerilustricostatus Ctriporin 19 5–10 >100 [74]
Mesobuthusmartensii BmKbpp 47 5.7–70 2.3–68.2 [66]
Vaejovismexicanus VmCT1 13 10–20 5–25 [67]
Vaejovismexicanus VmCT2 13 10–20 10–20 [67]
Androctonusamoreuxi AamAP1 18 20 150 [4]
Androctonusamoreuxi AamAP2 18 48 120 [4]
Scorpiopstibetanus StCT2 14 6.5–25 25–50 [75]
Heterometrusspinifer HsAP 29 11.8–46.5 23.8–51.2 [68]
Centruroidessuffusussuffuses Css54 25 12.5 12.5 [69]
Urodacusyaschenkoi UyCT1 14 15 10 [70]
Urodacusyaschenkoi UyCT2 13 ND 25–40 [70]
Urodacusyaschenkoi UyCT3 13 10 6–15 [70]
Urodacusyaschenkoi UyCT5 13 1 2–15 [70]
Pandinus imperator Pantinin-1 14 8–32 62–87 [71]
Pandinus imperator Pantini-2 13 18–48 48–87 [71]
Pandinus imperator Pantinin-3 13 4–16 36–87 [71]
Androctonusmauritanicus Mauriporin 48 5-10 5-10 [2]
Tityusserrulatus TsAP-1 17 120 160 [28]
Tityusserrulatus TsAP-2 17 5 >320 [28]
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formation after the initial attachment of peptides to 
microorganisms membranes [23,21].
Charge: Positive charge of cationic AMPs play an 
important role in the initial electrostatic attachment 
to the targeted negatively charged membranes 
components like acidic phospholipids, LPS and 
teichoic or teichuronic acid of gram negative and 
gram positive bacteria [15]. Many of AMPs are 
reported to have a net positive charge ranging from 
+2 to +9, there is a direct relationship between 
peptides net positive charge and activity within 
limited range differ in different peptides, increase 
the charge up the limit or decrease it below the 
limit resulted in the loss of optimum activity [24]. 
Amphipathicity & hydrophobic moment: 
Amphipathic molecule defined as molecule 
structurally contains both hydrophilic and 
hydrophobic domains, one way to express 
amphipathicity quantitatively by hydrophobic 
moment which defined as the sum of all amino 
acid residueshydrophobicities[25]With respect to 
the interdependent relationship between structural 
components that determine HDPs activity, when the 
hydrophobic moment increased the activity of HDPs 
toward pathogens negatively membranes increased 
with a remarkable higher activity against neutral or 
zwitterionic membranes [26].
Hydrophobicity: Defined as the percentage of 
hydrophobic amino acid residues compared with 
peptide total amino acids residues, approximately 
50% of hydrophobicity needed for optimum HDPs 
activity toward microorganism’s membranes and 
any increase over this percentage resulted in loss 
of antimicrobial specificity of HDPs [18].
Polar angle: Polar angle in amphipathic helix is 
defined as the proportion of polar sides compared 
with nonpolar ones. When polar sides decreased 
the proportion of hydrophobic surfaces increased 
which leads to increase antimicrobial activity against 
microorganisms membranes [27].
Antimicrobial peptides 
mechanisms of action 
The action of antimicrobial peptides toward 
bacterial membranes initiated by electrostatic 
interactions with negatively charged components 
of membranes like strong interaction with LPS in 
the outer membrane of gram negative bacteria and 
acidic phospholipids in the outer cell wall of gram 
positive bacteria, after the initial attachment AMPs 
aggregated within membranes then destruction 
of membranes have been achieved by channels 
(pores) formation [28,29].The exact mechanism of 
AMPs action against microorganisms membranes 
are not fully understood yet for all AMPs. However 
different models have been proposed previously to 
explain the process induced by AMPssuch as, barrel-
stave pore model, toroidal pore model (Figure 1), 
molecular electroporation and sinking-raft.
Barrel-Stave pore model: After the initial 
electrostatic attachment, the assembly of two or more 
AMPs in membranes is a critical role for membranes 
destruction by pores formation [30]. AMPs cross the 
bacterial membranes and form barrel like pores look 
like staves in which the hydrophobic part of AMPs is 
attached to inner lipid bilayer while the hydrophilic part 
of AMPs are facing the lumen of the pores [21,31].
Toroidal pore model: The mechanism of AMPs 
action as proposed by this model share a common 
features with the barrel-stave pore model although 
here the hydrophobic part of AMPs bind not only 
to the inner lipid bilayer but also to the outer layer, 
this conformation causing a strain on membranes 
leading to its destruction[32].Before AMPs action 
start to destruct membranes it continuo to 
aggregate until reach a threshold differ in different 
peptides defined as the concentration of peptides 
in compared with membrane lipids concentration 
(peptides to lipids ratio) [18, 33].
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 Carpet model: The carpet model propose 
that AMPs work like detergents, after the AMPs 
aggregate on the surface of membranes forming 
carpet structure and reach its defined threshold, 
the destruction starts and released patched of 
membrane look like micelles [34,35].
Molecular electroporation: Molecular electro- 
poration suppose that some peptides can form 
pores in targeted microorganisms membranes by 
electroporation in which AMPs creates electrostatic 
potential through the lipid bilayer responsible for 
pores generation and membrane destruction. These 
AMPs reported to have highly positively charged 
amino acids responsible for sufficient charge density 
to create the electrostatic potential [36].
Sinking-Raft model: As its name implies the 
model suppose that amphipathic peptides sink 
and bind to the membrane lipid bilayer, resulted in 
structurally imbalance. Their mechanism of action 
may through create temporarily pores with lethal 
effect on microorganisms [37].
Alternative antimicrobial peptides mecha- 
nisms: Most AMPs mechanisms of action have 
been identified to be pore formation and membrane 
destruction to the targeted microorganisms. 
However, other mechanisms rather than pore 
formation have been identified [33], for example 
some AMPs identified to act through inhibit 
either DNA synthesis or protein synthesis or both 
[38,39,40].
Resistance to antimicrobial 
peptides
Because microorganisms exposed to AMPs in 
different tissues of many organisms, the resistance 
to AMPs is difficult or somehow impossible also 
microorganism’s mutations to resist AMPs are rare 
[42]. The resistance to AMPs by human pathogen 
is recently accepted as one of the microorganism 
virulence factors, bacterial strains resistant to AMPs 
Figure 1. Three models represent the proposed AMPs mechanisms of action. (A) Barrel-stave pore model, (B) 
Carpet modeland (C)Toroidal pore model [78]. 
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also reported to be highly resistant to conventional 
antibiotics [43].
Microorganisms have two distant mechanisms 
to resist AMPs either by constitutive resistance 
(inherent resistance) or adaptive resistance 
(inducible resistance) [18], the microorganism’s 
strategies of resistance depend on counter the 
peptides mechanisms of action started with peptide 
electrostatic attachment with negatively charged 
components of microorganism’s membranes and 
ended mostly with pore formation leaded to 
membrane destruction [33,44].
Constitutive resistance is defined as permanent 
resistance of microorganisms to AMPs in the 
presence and the absence of peptides due to the 
presence of resistance factor always. Microorganisms 
constitutively resist the action of AMPs by using 
different mechanisms, for 
example resistance strains of Staphylococcus 
aureuscontain high D-alanylation of lipoteichoic 
acid with positively charged amine groups resulted 
in lowering the membrane negatively charge so lack 
of electrostatic affinity for AMPs toward membranes 
[45], another mechanism by membrane energy 
alteration, studies reports that microorganisms with 
altered membrane energetic are more resistance 
to AMPs action than microorganisms with normal 
membrane energy status, such as Candida albicans 
a respiratory deficient mutant fungi with membrane 
energy altered by lowered mitochondrial ATP 
synthesis [46] and S. aureus with membrane energy 
altered by constitutively reduced transmembrane 
potential [47]. Electrostatic shielding mechanism 
used also by microorganisms to resist the action of 
AMPs in which membranes have been covered with 
highly anionic glycocalyx or special capsule resulted 
in shield the lipid bilayer from AMPs [19].
Inducible resistance defined as the resistance 
mechanisms temporarily triggered in response to 
AMPs exposure with greatest aid to assist the survival 
of microorganisms. Adaptive resistance includes 
many mechanisms like: extracellular structural 
modifications, protease mediated microorganism’s 
resistance, efflux dependent resistance mechanisms, 
and modification of intracellular targets. Inducible 
resistance involved two component regulatory 
systems in many causes for example in gram 
negative bacteria Pho P/ Pho Q are two components 
of regulatory systems involved in microorganisms 
adaptive resistance in which AMPs act as ligands 
when it bind to bacterial sensory kinase Pho 
Q initiation of multiple adaptive responses and 
virulence mechanisms have been started [18].
Antimicrobial peptides 
therapeutic applications and 
drug development
Pathogenic microorganisms (microbes) have been 
reported to resist conventional used antibiotics, 
approximately 70% of bacterial strains that cause 
nosocomial infections are found to be resistance 
to one or more conventional used antibiotics also 
some strains have been reported to be multi-
resistance and other reported to resist almost all 
approved antibiotics [19]. Because of the structural 
and chemical nature diversity of AMPs, also the 
probability of microbes to resist AMPs is much 
lower than conventional antibiotics, make them a 
good candidate for a novel drug with anti bacterial, 
anti fungal and anti viral properties [48, 49]also 
Anti parasitic activity [50] and AMPs may used in 
treatment of cancer [51,52,53] and HIV infections 
[54].
As an example pexiganan (analog of magainin-2 
peptide), it has been reported to have a very potent 
activity against foot ulcers of diabetic patient and 
90% of treated patient with pexiganan reported to 
clinically cure or improve in phase III clinical trial [41].
Many pharmaceutical researches have been 
conducted to introduce AMPs to the market, during 
pharmaceutical development two main problems 
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arise, first the toxicity of AMPs against normal cells 
are not precisely can be predicted because AMPs 
targeted membranes lipids bilayer and they don’t 
have specific targets or receptors, and secondly 
AMPs don’t meet their primary end points during 
the development of pharmaceutical research to 
advanced clinical trials [77].As an example indolicidin 
(HDP) synthetic analogue called omiganan, a potent 
and a wide range in vitro antibacterial and antifungal 
activities of omiganan have been reported against 
broad spectrum of microorganisms [55], but when 
phase III clinical trial has been conducted omiganan 
failed to targeted the primary ends points [33], 
another difficulty face the development of clinical 
trials is the cost of commercial pharmaceutical 
production, as the one gram of HDPs cost from 
100-600 US dollars [56].
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